» Articles » PMID: 30466437

Association Between Patient-reported HIV Status and Provider Recommendation for Screening in an Opportunistic Cervical Cancer Screening Setting in Jos, Nigeria

Overview
Publisher Biomed Central
Specialty Health Services
Date 2018 Nov 24
PMID 30466437
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cervical cancer screening (CCS) is an important health service intervention for prevention of morbidity and mortality from invasive cervical cancer. The role of provider recommendation and referral is critical in utilization of this services particularly in settings where screening is largely opportunistic. We sought to understand how patient-reported human immunodeficiency virus (HIV) infection status is associated with provider referral in an opportunistic screening setting.

Methods: We performed a cross-sectional analysis of data on a sample of women who had received a CCS at the "Operation Stop" cervical cancer (OSCC) screening service in Jos, Nigeria over a 10-year time period (2006-2016). We used the de-identified records of women who had their first CCS to analyze the association between patient-reported HIV and likelihood of provider-referral at first CCS. We performed descriptive statistics with relevant test of association using Student t-test (t-test) for continuous variables and Pearson chi square or Fisher exact test where applicable for categorical variables. We also used a bivariable and multivariable logistic regression models to estimate the independent association of patient-reported HIV on provider referral. All statistical tests were performed using STATA version 14.1, College Station, Texas, USA. Level of statistical significance was set at 0.05.

Results: During the 10-year period, 14,088 women had their first CCS. The reported HIV prevalence in the population was 5.0%; 95% CI: 4.6, 5.4 (703/14,088). The median age of women who were screened was 37 years (IQR; 30-45). Women who were HIV infected received more referrals from providers compared to women who were HIV uninfected (68.7% versus 49.2%), p-value < 0.001. Similarly, we found an independent effect of patient-reported HIV infection on the likelihood for provider-referral in the screened sample (aOR = 2.35; 95% CI: 1.95, 2.82).

Conclusion: Our analysis supports the design of health systems that facilitates providers' engagement and provision of necessary counseling for CCS in the course of routine clinical care. The practice of offering recommendation and referrals for CCS to women at high risk of cervical cancer, such as HIV infected women should be supported.

Citing Articles

Factors Influencing Cervical Cancer Screening: A Cross-Sectional Study Among Ethnically Diverse Women in the Kumasi Metropolis of Ghana.

Abubakari A, Gross J, Kwaku I, Boateng I Health Sci Rep. 2025; 8(2):e70433.

PMID: 39949523 PMC: 11821460. DOI: 10.1002/hsr2.70433.


Early age at menarche and history of sexually transmitted infections significantly predict cervical cancer screening uptake among women aged 25-49 years: evidence from the 2021 Côte d'Ivoire demographic and health survey.

Okyere J, Ayebeng C, Dickson K BMC Health Serv Res. 2024; 24(1):423.

PMID: 38570834 PMC: 10993584. DOI: 10.1186/s12913-024-10881-9.


The impact of the COVID-19 pandemic on routine HIV care and cervical cancer screening in North-Central Nigeria.

Habila M, Obeng-Kusi M, Ali M, Magaji F, Shambe I, Daru P BMC Womens Health. 2023; 23(1):640.

PMID: 38037005 PMC: 10687784. DOI: 10.1186/s12905-023-02782-6.


Utilization of opportunistic cervical cancer screening in Nigeria.

Habila M, Sagay E, Obeng-Kusi M, Ali M, Magaji F, Shambe I Cancer Causes Control. 2023; 35(1):9-20.

PMID: 37530986 DOI: 10.1007/s10552-023-01764-1.


Correlates of cervical cancer screening participation, intention and self-efficacy among Muslim women in southern Ghana.

Enyan N, Davies A, Opoku-Danso R, Annor F, Obiri-Yeboah D BMC Womens Health. 2022; 22(1):225.

PMID: 35698121 PMC: 9189795. DOI: 10.1186/s12905-022-01803-0.


References
1.
Allemani C, Weir H, Carreira H, Harewood R, Spika D, Wang X . Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2014; 385(9972):977-1010. PMC: 4588097. DOI: 10.1016/S0140-6736(14)62038-9. View

2.
Odafe S, Torpey K, Khamofu H, Oladele E, Adedokun O, Chabikuli O . Integrating cervical cancer screening with HIV care in a district hospital in Abuja, Nigeria. Niger Med J. 2013; 54(3):176-84. PMC: 3719244. DOI: 10.4103/0300-1652.114590. View

3.
Labeit A, Peinemann F, Kedir A . Cervical cancer screening service utilisation in UK. Sci Rep. 2013; 3:2362. PMC: 3734438. DOI: 10.1038/srep02362. View

4.
Lantz P, Mullen J . The National Breast and Cervical Cancer Early Detection Program: 25 Years of public health service to low-income women. Cancer Causes Control. 2015; 26(5):653-6. DOI: 10.1007/s10552-015-0565-9. View

5.
Twinomujuni C, Nuwaha F, Babirye J . Understanding the Low Level of Cervical Cancer Screening in Masaka Uganda Using the ASE Model: A Community-Based Survey. PLoS One. 2015; 10(6):e0128498. PMC: 4451264. DOI: 10.1371/journal.pone.0128498. View